drugset
drugset / Trial / NCT00914160

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

NCT00914160 ↗

Phase 1 Completed 18 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets under non-fasting conditions.

Timeline

Start
1993-08
Primary completion
1993-09
Completion
1993-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 50 mg —

Indications

No indication recorded.